Completed PHASE3 INTERVENTIONAL 1-arm NCT00838812

Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate

Monocentric Study, Prospective, Open and Non Controlled for to Evaluate the Effectiveness, and Tolerability the Safety of Association of Clindamycin Phosphate 1.2% and Tretinoin 0,025% in the Treatment of Acne Vulgaris Mild to Moderate, When Used Once Daily for 12 Weeks.

Sponsor: Igefarma Laboratorios S.A.

Conditions Acne Vulgaris

Interventions application of the topic gel

Updated 5 times since 2017 Last updated: May 24, 2010 Started: Mar 31, 2009 Primary completion: Jan 31, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Acne Vulgaris and is currently completed. Igefarma Laboratorios S.A. leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Igefarma Laboratorios S.A.

Data source: Igefarma Laboratorios S.A.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valinhos, Brazil